Prospective, Single Arm, Single Center Study of Duvelisib Combined With Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma (PTCL)
Condition: Newly Diagnosed Peripheral T-cell Lymphoma Intervention: Drug: Duvelisib, Chidamide Sponsors: Liling Zhang; CSPC Ouyi Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials